Cholesterol Drug Trilipix May Not Lower Heart Risk
U.S. Food and Drug Administration officials have announced that cholesterol-lowering drug fenofibric acid (Trilipix) might not lower a patient's risk of having a heart attack or stroke.
Your DNA Could be Problematic for Statins
Statins are widely prescribed to lower cholesterol and reduce the risk of heart attacks and strokes. Though effective, some doctors have become concerned about a rare gene that increases the risk of muscle aches, kidney damage and death in those who also take statins.
Why Statins Don't Always Work
For some patients, statins simply aren't effective at lowering their high cholesterol. Now scientists think they may have figured out why the cholesterol-lowering drugs don't work well in some patients.
New Drug Treats Diabetes and High Cholesterol
The FDA has approved Juvisync, a prescription medication that contains two previously approved medicines in one tablet: Januvia (sitagliptin) for diabetes and Zocor (simvastatin) for high cholesterol.
(UPDATE 12/15) FDA Announces New Safety Recommendations For High-Dose Simvastatin
The U.S. Food and Drug Administration today is announcing safety label changes for the cholesterol-lowering medication simvastatin because the highest approved dose--80 milligram (mg)--has been associated with an elevated risk of muscle injury or myopathy , particularly during the first 12 months of use.